Takeda: Renal Insufficiency trials

The registry lists 23 Renal Insufficiency studies with Takeda as lead sponsor. 1 are open to participants now and 14 have results posted.

Phase 1 8Phase 2 5Phase 3 5Phase 4 3No phase 2(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Study of Maribavir in Adults With Kidney Failure Who Have a Cytomegalovirus (CMV) Infection After TransplantationRecruitingNCT06243731
• A Study of Mobocertinib Capsules in People With Severe Kidney Problems and People With Healthy KidneysCompletedNCT04056455Phase 1Results posted
• A Study of Pevonedistat in People With Blood Cancers or Solid Tumors With Kidney or Liver ProblemsCompletedNCT03814005Phase 1Results posted
• A Study to Evaluate the Effect of Renal Impairment and Dialysis Treatment on the Pharmacokinetics (PK) of a Single Intravenous (IV) TAK-954CompletedNCT03296787Phase 1Results posted
• Phase I Open-label Study to Evaluate Pharmacokinetics of TAK-272 in Participants With Renal or Hepatic ImpairmentCompletedNCT02367872Phase 1Results posted
• Efficacy and Safety of Extended Release and Immediate Release Febuxostat in Participants With Gout and Moderate Renal ImpairmentCompletedNCT02128490Phase 2Results posted
• Study of SSP-004184 (FBS0701) in Healthy Adults and Elderly Subjects and in Subjects With Impaired Renal FunctionCompletedNCT01716455Phase 1Results posted
• Healthy and Renal Impairment Study of Colcrys (Colchicine, USP)CompletedNCT01084278Phase 4Results posted
• Effect of Febuxostat on Renal Function in Patients With Gout and Moderate to Severe Renal ImpairmentCompletedNCT01082640Phase 2Results posted
• Comparing Absorption of Dietary Phosphorus When Administering FOSRENOL® or RENVELA® in Healthy Adult VolunteersCompletedNCT00875017Phase 1Results posted
• Safety and Efficacy of Peginesatide Injection for the Maintenance of Anemia in Chronic Renal Failure Participants Who Are on Hemodialysis or Do Not Require Dialysis and Previously Treated With Darbepoetin Alfa.CompletedNCT00752609Phase 2Results posted
• DELFT (Dynepo Evaluation of Long-Term Follow-Up Treatment)TerminatedNCT00664066Results posted
• Dynepo Long-Term Safety StudyTerminatedNCT00514813Phase 4Results posted
• Dynepo Infrequent Dosing StudyTerminatedNCT00450333Phase 3Results posted
• Efficacy and Safety of Peginesatide (AF37702) in the Treatment of Anemia in Participants With Chronic Kidney DiseaseCompletedNCT00314795Phase 2Results posted
• A Study of TAK-279 in Adults With or Without Kidney ProblemsCompletedNCT05992155Phase 1
• Pharmacokinetics of 10 mg Teduglutide in Subjects With Renal Impairment Compared to Healthy Subjects With Normal Renal FunctionCompletedNCT01028768Phase 1
• Efficacy of Pioglitazone and Insulin in Treating Subjects With Type 2 Diabetes Mellitus and Renal Failure.CompletedNCT00770640Phase 2
• Efficacy and Safety of Fosrenol in Treating Elevated Serum Phosphate Levels in Adults With End Stage Renal DiseaseCompletedNCT00160121Phase 4
• Efficacy and Tolerability of Treatment With Lanthanum Carbonate in Patients With End Stage Renal Disease Receiving DialysisCompletedNCT00151931Phase 3
• Efficacy and Safety of Lanthanum Carbonate and Sevelamer Hydrochloride in Patients Receiving Haemodialysis for End Stage Renal DiseaseCompletedNCT00151918Phase 3
• Efficacy and Safety of Lanthanum in Controlling Serum Phosphate Levels in Subjects With End Stage Renal Disease Who Require Treatment for High Levels of Phosphate in Their BloodCompletedNCT00150566Phase 3
• A Long Term Study of Lanthanum Carbonate in Patients Requiring Dialysis Who Have Ived Lanthanum Carbonate in Previous Studies Defined by the Protocol.CompletedNCT00150540Phase 3